Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (8683)	2/11/1999 3:48:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

Oh, I was almost sure you were Hassan. BTW most of the real targets for PNU are up several bucks apiece, per share. Coincidence? I don't think so! +TexasDude (28182 ) From: +george wohanka Thursday, Feb 11 1999 11:33AM ET Reply # of 28184 What happened to stealth? This guy has a big mouth. I would fire him, but first they would have to hire me, as his boss. His comments are going to help increase the prices of some of the stocks he will be trying to buy. His competition is also paying attention. Bad enough that it must be difficult to keep plans under wraps... Just an example of such gross stupidity. Expect Hassan to start posting here soon. Disregard the fact that he earns and is worth millions more than I do. He is an idiot. So at least we have something in common.<g> ''This will be a change because up until now P&U was trying to get its own act together. Now that we have a top management team in place we are able to absorb acquisitions,'' Hassan said, adding it would do so armed with ''a strong balance sheet.'' ''We will be a very active company in the deal flow. We are going to be very flexible and very fast on our feet when opportunities arise. We will be going into the next phase of our company's growth,'' Hassan said. Hassan, in a telephone interview, said he planned to begin the acquisition efforts ''this year or next year,'' although he cautioned it was impossible to guarantee any timeframe for clinching such deals. He said P&U could afford to go after companies ''worth several billions of dollars'' and was most interested in biotech concerns located in the United States, although it might also target companies located in Europe and Asia.